Investing
Thermo Fisher Scientific·Cash Flow Statement·8 metrics
Breakdown
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Net cash from investing activities | -$253M | -$3.6B | $0 | -$527M | -$288M | -$4.1B | — | -$9B |
| Acquisitions, net of cash acquired | $0 | $3.1B | $0 | $0 | — | — | — | $8.9B |
| Capital expenditures | $301M | $272M | $480M | $362M | $294M | $404M | $465M | $376M |
| Proceeds from disposition of marketable securities and other investments | — | — | $1.8B | $2M | — | — | $1.3B | $250M |
| Proceeds from Cross-Currency Swap Interest Settlements | $47M | $92M | $49M | $87M | $47M | $84M | $50M | $96M |
| Payment for (Proceeds from) Other Investing Activity | -$5M | -$2M | -$3M | $1M | -$7M | -$14M | -$1M | $55M |
| Purchases of investments | $20M | $287M | $1.3B | $264M | $47M | $40M | $32M | $14M |
| Proceeds from disposals of property, plant and equipment | $16M | $20M | $17M | $12M | $1M | $4M | $27M | $9M |